Edwards Lifesciences Corporation Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31)
Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) of -$3.10 million for the 3-month period ending 2011-06-30, per its 10-Q filed 2011-08-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease · last filed 2011-08-08
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was -$3.10M, a 144.29% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-03-31 was -$7.10M, a 204.41% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2010-06-30 was $7.00M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2010-03-31 was $6.80M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2010 was -$6.80M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2009 was -$3.50M, a 171.43% decline from fiscal 2008.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2008 was $4.90M.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|
| 2011-06-30 | -$3.10M 10-Q · filed 2011-08-08 | -$10.20M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | -$7.10M 10-Q · filed 2011-05-09 | ||
| 2010-12-31 | -$6.80M 10-K · filed 2011-02-28 | ||
| 2010-06-30 | $7.00M 10-Q · filed 2011-08-08 | $13.80M 10-Q · filed 2011-08-08 | |
| 2010-03-31 | $6.80M 10-Q · filed 2011-05-09 | ||
| 2009-12-31 | -$3.50M 10-K · filed 2011-02-28 | ||
| 2008-12-31 | $4.90M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |